Commercialization: Page
-
PharmaVoice Team/PharmaVoice
Outsourcing: A Vital Clinical Strategy
Outsourcing: A Vital Clinical Strategy A large, unmet need exists for improved research and development productivity within pharmaceutical and biotechnology companies. Outsourcing discovery research, clinical trials, and formulation manufacturing ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Talent Pool
Pharma POOL Michael J. DuBois Jeffrey A. Winton Schering-Plough Announces VP Appointments Schering-Plough, Kenilworth, N.J., has appointed Michael J. DuBois senior VP of global licensing. In this role, Mr. DuBois, 56, is responsible for the acquisition of new products discovered outside Schering-...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
The Continuing Evolution of EDC
Paper may still reign supreme, but the EDC industry is coming of age. There is widespread agreement — at least intuitively — that the use of an electronic device or software application that allows direct data entry into electronic format has the potential to reduce time and money within the drug...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Flying High On A Vision
Flying High on a Vision By Kim Ribbink Entrepreneurs are individuals who make innovation possible; they are the people who stake their reputation, finances, and future on running their own businesses and achieving something different. As pharmaceutical and service companies continue to merge, bus...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Talent Pool
Pharma POOL Jean-Louis Anspach Michael R. Dornhecker Ann Willmoth Solvay Pharmaceuticals Announces Key Promotions Solvay Pharmaceuticals, Marietta, Ga., has named Jean-Louis Anspach as VP, commercial operations, responsible for managing all aspects of the primary-care business unit, including sal...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Ideology Vs. Science: The Stem-Cell Battle
Ideology Vs. Science: The Stem-Cell Battle By Kim Ribbink Across the globe, scientists are extolling the potential of stem- cell research to cure debilitating diseases, in spite of limits on federal funding as well as controversy surrounding the research. States and private investors have begun t...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
DTC: The Next Phase
In light of FDA guidances, more public scrutiny, and trending corporate citizenship, DTC advertising is subtly shifting to direct-to-education. Direct-to-consumer advertising has been mainly focused on creating brand awareness for major blockbuster products, or creating awareness for new therapeu...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
PharmaOutlet
Contributed by Colin J. Foster In the Aftermath of September 11, U.S. Security is A New Reason to Improve Science Education Innovations in science and technology have long been synonymous with economic prosperity. On the other hand, it’s probably safe to say that science and technology and the st...
By Colin J. Foster • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Raise Your Voice -- Letters
Letters Informative DTC ads still have a long way to go. Hold the dogs, skateboards, straw hats, happy motorcycling couples, and all those grandkids. — Carol Bohach, B.S.Pharm. Clinical Research Consultant November 2003 Advertising and patient education need to join hands Back in the 1980s, I wro...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Integration Architects: The Bridge to Peak Technological Solutions
Integration Architects: The Bridge to Peak Technological Solutions One critical and often overlooked member of the core project team is the integration architect, who defines and translates key information across technology applications. Yet many organizations do not explicitly define these posit...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
What's New
GSW Opens New York Office New location solidifies inChord’s presence in the Northeast pharmaceutical corridor and facilitates interaction between other East Coast corporate entities. Gerbig, Snell/Weisheimer (GSW) has recently expanded its operations by opening an office in New York. The new offi...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
PharmaTrax
Pharma Trax Sales, marketing, And R&D Trends affecting the healthcare industry Rising Drug Expenditures Spur Rx-to-OTC Switches Rising prescription drug spending in both the United States and Europe is prompting an increase in the change of drugs from prescription to over-the-counter (OTC) st...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
For Art's Sake
Each month, this department pays homage to memorable advertising and marketing campaigns. The highlighted executions have been identified by leading creative executives for their noteworthy use of copy, art, photography, whimsy, uniqueness, etc. — in combination or as single branding elements. Cr...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
On the Calendar
November 18-20, 2003, Westin Copley Place — Boston LogiPharma 2003 This is an opportunity for attendees to hear how competitors and peers are maximizing every facet of their supply-chain strategy. The event provides the opportunity to hear more than 25 confirmed case studies delivered by senior-l...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Table of Contents
On The Cover Flying high on a vision Even as pharmaceutical companies merge to form giant conglomerates, business leaders are choosing to step out on their own and are taking some calculated risks. They embrace the challenges that come with being an entrepreneur and strive to make a difference in...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
Letter from the Editor By Taren Grom Editor Driving business forward According to the U.S. Small Business Administration, more than 50% of small businesses fail in the first year and 95% fail within the first five years. Some entrepreneurs describe their decision to set up their own business as a...
By Taren Grom • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
What's on Your Mind -- Opinions
Opinions What’s on your mind What have you heard lately? In the September issue of PharmaVOICE, we asked readers to relate the most surprising statistics or strange facts that they have come across. PharmaVOICE learned that every human spent about half an hour as a single cell and that 70% of con...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
What's New
New Healthcare-related Products, Services, and Companies PMI Appoints Task Force to Oversee CME Compliance Pri-Med Institute (PMI) has named a task force of medical and educational experts to ensure that all of its continuing medical education (CME) programs meet and exceed the new Standards of C...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
On the Calendar
June 6-7 Pharmaceutical Marketers KnowledgeShare Forum 2005: Building Brand Differentiation in the Current Regulatory Climate Airport Marriott, Philadelphia This is a PharmaVOICE event, subscribers are eligible for a 15% discount; register using code PVMKS05. For more information, contact Micah L...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Table of Contents
on the cover The time for transparency The government, medical journal editors, and general public are clamoring for the pharmaceutical industry to provide complete information about ongoing and completed clinical trials. There has been a flurry of activity, announcements, and mandates in this ar...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Cover
Clinical-Trial Transparency: The Pros and Cons Representing Biotech with David King DTC: The Next Evolution PharmaVOICE www.pharmavoice.com June 2005 Volume 5, Number 6 Download PDF
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
For Art's Sake
Each month, this department pays homage to memorable advertising and marketing campaigns. The highlighted executions have been identified by leading creative executives for their noteworthy use of copy, art, photography, whimsy, uniqueness, etc. — in combination or as single branding elements. Cr...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
PharmaTrax
CME Programs Accredited by Universities and Societies Receive Preference Continuing medical education (CME) programs created by medical communications agencies achieve a higher level of acceptance among physicians when they are accredited through partnerships with respected university medical sch...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Risk Aversion As a Profitability-Limiting Factor in Clinical-Trial Conduct
Risk Aversion As a Profitability-Limiting Factor in Clinical-Trial Conduct What is risk? Why does it matter? Shouldn’t prudent business people try to avoid it? How does it impact the conduct of clinical trials, and can it or should it change? Timothy Pratt, Ph.D., Chief marketing officer of MedNe...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
PharmaOutlet
Contributed by Jim Montgomery Building Effective Communications For the Life-Sciences Marketplace Open the latest issue of Science or Biotechniques, and browse through the ads. But be forewarned; it’s not pretty. First, there are the companies that clearly aspire to be marketers, all of them stru...
By Jim Montgomery • Jan. 2, 2008
Previous
